Business Context and Reporting Period
Company: Healthcare Triangle, Inc. (HCTI)
Filing Type: Form 8-K (Current Report)
Date of Report: July 30, 2025
Event Date: August 1, 2025
Context: The Company, an emerging growth company listed on the Nasdaq Capital Market, filed this report to disclose a material corporate action taken to maintain its listing status.
Key Financial Metrics
This filing is a current report regarding a corporate governance event and does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The filing text does not provide a clear value for these metrics.
Material Changes Versus Prior Period
The primary material change disclosed is a significant reduction in the number of outstanding shares due to a reverse stock split:
- Reverse Stock Split Ratio: 1-for-249 (1:249).
- Pre-Split Shares Outstanding: 1,452,124,283.
- Post-Split Shares Outstanding: 5,831,816.
- Authorized Shares: Remained unchanged.
- Ownership Impact: The split did not alter any stockholder's percentage ownership interest, except for the rounding up of fractional shares to the next whole share.
- Adjustments: Outstanding warrants, stock options, convertible securities, and equity incentive plan reserves were proportionally adjusted.
Guidance, Outlook, Risks, and Unusual Items
Purpose of Action: The reverse stock split was implemented to bring the Company into compliance with the $1.00 minimum bid price requirement for continued listing on the Nasdaq Capital Market (Nasdaq Listing Rule 5550(a)(2)).
Trading Details:
- Trading on a split-adjusted basis commenced on August 1, 2025.
- Trading Symbol: Remains "HCTI".
- New CUSIP: 42227W 306.
Risks and Contingencies:
- Delisting Risk: Forward-looking statements highlight the risk that the Company may not successfully appeal a Nasdaq staff delisting determination.
- OTC Trading: There is a risk that if delisted from Nasdaq, the Company may need to apply to trade on the OTCQB market, which may not be approved timely.
- General Risks: The filing references the "Risk Factors" section of the Annual Report on Form 10-K filed on March 31, 2025, for a comprehensive list of uncertainties.
Important Facts for Investor Verification
- Verify the post-split share count of 5,831,816 in brokerage accounts.
- Confirm the new CUSIP number (42227W 306) for trading purposes.
- Review the status of the Nasdaq compliance application to ensure continued listing.
- Check for proportional adjustments to any held options, warrants, or convertible securities.
- Monitor for any subsequent filings regarding the outcome of the Nasdaq listing compliance review.